Skip to main content

Biologics

Biologics

Epiregulin Inhibition to Treat Scleroderma Skin and Lung Fibrosis

ReImmune: A Disposable Bed-Side Device for T cell Immunotherapy without Genetic Engineering

Targeting Profibrotic Macrophages Using Mir-33 Inhibitors, a Novel Therapeutic Approach for Pulmonary Fibrosis

First-in-Class Humanized Anti-DKK2 for Colorectal Cancer

Reversing Axonal Spheroids and Conduction Defects in Alzheimer’s Disease

Novel Therapeutic for the Treatment of Renal Cell Carcinoma

Metabolically Enhanced CAR-T Cell Therapy

RIGImmune: Harnessing the Innate Immune System

Target Site Blocker (TSB) of the IL-17A-miR466I-3p iInteraction Prevents Progressive and Relapsing Remitting EAE

Paci-PHI: Evolution-Proof Therapy Against MDR Bacterial Pathogens

Subscribe to Biologics